In the past week, ISPC stock has gone up by 13.43%, with a monthly decline of -6.31% and a quarterly plunge of -2.00%. The volatility ratio for the week is 16.50%, and the volatility levels for the last 30 days are 18.03% for iSpecimen Inc The simple moving average for the last 20 days is 7.73% for ISPC stock, with a simple moving average of -21.11% for the last 200 days.
Is It Worth Investing in iSpecimen Inc (NASDAQ: ISPC) Right Now?
The stock has a 36-month beta value of 1.59. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ISPC is 0.65M, and at present, short sellers hold a 1.30% of that float. On November 05, 2024, the average trading volume of ISPC was 295.46K shares.
ISPC) stock’s latest price update
iSpecimen Inc (NASDAQ: ISPC)’s stock price has plunge by 12.90relation to previous closing price of 4.34. Nevertheless, the company has seen a 13.43% surge in its stock price over the last five trading sessions. globenewswire.com reported 2024-10-31 that WOBURN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the closing of its previously announced public offering of approximately $5 million of the Company’s common stock and pre-funded warrants to purchase shares of common stock at a public offering price of $3.00 per share (minus $0.0001 per pre-funded warrant). The Company intends to use the proceeds of the offering for repayment of outstanding debt, potential acquisitions of assets or investments in businesses, products and technologies and for marketing and advertising services. The remainder of the proceeds will be used for working capital purposes.
ISPC Trading at 1.02% from the 50-Day Moving Average
After a stumble in the market that brought ISPC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -66.44% of loss for the given period.
Volatility was left at 18.03%, however, over the last 30 days, the volatility rate increased by 16.50%, as shares surge +1.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.98% lower at present.
During the last 5 trading sessions, ISPC rose by +13.43%, which changed the moving average for the period of 200-days by -48.50% in comparison to the 20-day moving average, which settled at $4.55. In addition, iSpecimen Inc saw -51.06% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ISPC
Current profitability levels for the company are sitting at:
- -0.98 for the present operating margin
- 0.34 for the gross margin
The net margin for iSpecimen Inc stands at -0.97. The total capital return value is set at -1.68. Equity return is now at value -98.03, with -69.19 for asset returns.
Based on iSpecimen Inc (ISPC), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -168.22. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -573.44.
Currently, EBITDA for the company is -9.1 million with net debt to EBITDA at 0.25. When we switch over and look at the enterprise to sales, we see a ratio of 0.19. The receivables turnover for the company is 3.69for trailing twelve months and the total asset turnover is 0.88. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.90.
Conclusion
To sum up, iSpecimen Inc (ISPC) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
